“HPV Vaccine Push Not Based On Evidence”
New data published online December, 2011 in the Annals of Medicine states that U.S. policy for human papilloma virus (HPV) is at odds with evidence-based medicine. Canadian researchers found that there is a major discrepancy in claims regarding the safety and efficacy of Gardasil (Merck & Co) and Cervarix (GlaxoSmithKline), the 2 vaccines currently heavily marketed. These vaccines are backed by government agencies in the U.S., including the CDC and the FDA. Yet, since its approval in 2006, HPV vaccination has been mired in controversy over safety issues and mandatory vaccination for young girls (and possibly, soon for boys). Skepticism about the vaccine has been increasing for a number of reasons, despite reassurances from the public-health sector.
